The Drug Safety Strategies to De-Risk Compounds conference, held in Boston, included topics covering new developments in the field of drug safety. This conference report highlights selected presentations on the early prediction of hepatotoxicity, improvements in models of cardiovascular toxicity, the use of biomarkers in drug development, and computational approaches to drug safety predictions. Emerging technologies and drug safety models, as well as case studies of safety assessment advances, are also discussed.